| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |